ACACB

ACACB
Identifiers
AliasesACACB, ACC2, ACCB, HACC275, acetyl-CoA carboxylase beta, ACC-beta, ACCbeta, ACACbeta
External IDsOMIM: 601557; MGI: 2140940; GeneCards: ACACB
Available structures
PDBOrtholog search: PDBe RCSB
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
6.4.1.2↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_001093

NM_133904

RefSeq (protein)

NP_001084

NP_598665
NP_001390456
NP_001390457
NP_001390458

Location (UCSC)Chr 12: 109.12 – 109.27 MbChr 5: 114.28 – 114.39 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Acetyl-CoA carboxylase 2 also known as ACC-beta or ACC2 is an enzyme that in humans is encoded by the ACACB gene.

Function

Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine palmitoyltransferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis.

Clinical implications

Human acetyl-CoA carboxylase has recently become a target in the design of new anti-obesity drugs. However, when the gene for ACC2 was knocked out in mice, no change in body weight was observed relative to normal mice. This result suggests inhibition of ACC2 by drugs may be an ineffective method of treating obesity.